Investing
InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for...
Hi, what are you looking for?
Sun Summit Minerals Corp. (TSXV: SMN,OTC:SMREF) (OTCQB: SMREF) (‘Sun Summit’ or the ‘Company’) is pleased to announce that, due to significant investor demand, it has increased...
InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for...
Japan’s largest copper smelter has secured a rare reprieve in one of the tightest processing-fee environments the industry has ever seen. According to media...
With gains of nearly 30 percent in 2024, gold has outpaced many other investments since the start of 2024. The final high of Q3...
Meteoric Resources NL (ASX: MEI) (Meteoric or the Company) encloses a replacement ASX release relating to the updated Caldeira Scoping Study released today. The...
Lithium carbonate values saw further declines in the third quarter, starting the 90 day session at US$12,999 per metric ton and shedding 22 percent...
Group Eleven Resources Corp. (TSXV: ZNG) (OTCBB: GRLVF) (FSE: 3GE) (‘Group Eleven’ or the ‘Company’) is pleased to announce results from a recent step-out...
MAVERIC-2 trial will evaluate the impact of CardiolRx(TM) following cessation of interleukin-1 blocker therapy (rilonacept or anakinra) and is expected to run concurrently with...